Simulations Plus Retained Earnings (Accumulated Deficit) 2010-2024 | SLP
Simulations Plus retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Simulations Plus Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024 |
$30 |
| 2023 |
$25 |
| 2022 |
$40 |
| 2021 |
$32 |
| 2020 |
$27 |
| 2019 |
$22 |
| 2018 |
$18 |
| 2017 |
$14 |
| 2016 |
$11 |
| 2015 |
$10 |
| 2014 |
$9 |
| 2013 |
$9 |
| 2012 |
$11 |
| 2011 |
$10 |
| 2010 |
$7 |
| 2009 |
$5 |
Simulations Plus Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-08-31 |
$30 |
| 2024-05-31 |
$31 |
| 2024-02-29 |
$29 |
| 2023-11-30 |
$26 |
| 2023-08-31 |
$25 |
| 2023-05-31 |
$26 |
| 2023-02-28 |
$27 |
| 2022-11-30 |
$40 |
| 2022-08-31 |
$40 |
| 2022-05-31 |
$40 |
| 2022-02-28 |
$37 |
| 2021-11-30 |
$34 |
| 2021-08-31 |
$32 |
| 2021-05-31 |
$33 |
| 2021-02-28 |
$31 |
| 2020-11-30 |
$29 |
| 2020-08-31 |
$27 |
| 2020-05-31 |
$26 |
| 2020-02-29 |
$24 |
| 2019-11-30 |
$23 |
| 2019-08-31 |
$22 |
| 2019-05-31 |
$21 |
| 2019-02-28 |
$19 |
| 2018-11-30 |
$18 |
| 2018-08-31 |
$18 |
| 2018-05-31 |
$18 |
| 2018-02-28 |
$17 |
| 2017-11-30 |
$14 |
| 2017-08-31 |
$14 |
| 2017-05-31 |
$13 |
| 2017-02-28 |
$12 |
| 2016-11-30 |
$12 |
| 2016-08-31 |
$11 |
| 2016-05-31 |
$11 |
| 2016-02-29 |
$10 |
| 2015-11-30 |
$10 |
| 2015-08-31 |
$10 |
| 2015-05-31 |
$10 |
| 2015-02-28 |
$9 |
| 2014-11-30 |
$9 |
| 2014-08-31 |
$9 |
| 2014-05-31 |
$10 |
| 2014-02-28 |
$9 |
| 2013-11-30 |
$9 |
| 2013-08-31 |
$9 |
| 2013-05-31 |
$10 |
| 2013-02-28 |
$9 |
| 2012-11-30 |
$10 |
| 2012-08-31 |
$11 |
| 2012-05-31 |
$11 |
| 2012-02-29 |
$11 |
| 2011-11-30 |
$11 |
| 2011-08-31 |
$10 |
| 2011-05-31 |
$10 |
| 2011-02-28 |
$9 |
| 2010-11-30 |
$8 |
| 2010-08-31 |
$7 |
| 2010-05-31 |
$7 |
| 2010-02-28 |
$6 |
| 2009-11-30 |
$5 |
| 2009-08-31 |
$5 |
| 2009-05-31 |
$5 |
| 2009-02-28 |
$4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.552B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
